- Home
- CLGN vs FMST Comparison
CLGN vs FMST Comparison
Compare CLGN & FMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- FMST
- Stock Information
- Founded
- CLGN 2004
- FMST 2005
- Country
- CLGN Israel
- FMST Canada
- Employees
- CLGN N/A
- FMST N/A
- Industry
- CLGN Industrial Specialties
- FMST Other Metals and Minerals
- Sector
- CLGN Health Care
- FMST Basic Materials
- Exchange
- CLGN Nasdaq
- FMST Nasdaq
- Market Cap
- CLGN 33.8M
- FMST 38.2M
- IPO Year
- CLGN N/A
- FMST N/A
- Fundamental
- Price
- CLGN N/A
- FMST $4.30
- Analyst Decision
- CLGN Strong Buy
- FMST
- Analyst Count
- CLGN 2
- FMST 0
- Target Price
- CLGN $11.50
- FMST N/A
- AVG Volume (30 Days)
- CLGN 257.5K
- FMST 701.6K
- Earning Date
- CLGN 11-26-2025
- FMST 11-21-2025
- Dividend Yield
- CLGN N/A
- FMST N/A
- EPS Growth
- CLGN N/A
- FMST N/A
- EPS
- CLGN N/A
- FMST N/A
- Revenue
- CLGN $2,402,000.00
- FMST N/A
- Revenue This Year
- CLGN $1,617.28
- FMST N/A
- Revenue Next Year
- CLGN $83.54
- FMST N/A
- P/E Ratio
- CLGN N/A
- FMST N/A
- Revenue Growth
- CLGN 248.62
- FMST N/A
- 52 Week Low
- CLGN $1.31
- FMST $0.55
- 52 Week High
- CLGN $4.99
- FMST $5.74
- Technical
- Relative Strength Index (RSI)
- CLGN 45.87
- FMST 70.33
- Support Level
- CLGN $2.11
- FMST $3.09
- Resistance Level
- CLGN $2.44
- FMST $3.79
- Average True Range (ATR)
- CLGN 0.22
- FMST 0.34
- MACD
- CLGN -0.03
- FMST 0.10
- Stochastic Oscillator
- CLGN 23.36
- FMST 87.86
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.